Literature DB >> 26064461

Severe pulmonary arterial hypertensive rats are tolerant to mild exercise.

Leslie A Hargett1, Lauren J Hartman1, April K Scruggs1, Jared M McLendon2, April K Haven1, Natalie N Bauer1.   

Abstract

A frequently used end point of clinical outcomes in patients with pulmonary arterial hypertension (PAH) is the 6-minute walk distance. Furthermore, some data suggest that mild to moderate exercise as an intervention in stable PAH is beneficial. Some of these questions have been recapitulated in the monocrotaline and hypoxia animal models of pulmonary hypertension. However, mild exercise and walk distance as end points have not been rigorously examined in the severe progressive Sugen 5416/hypoxia/normoxia (Su/Hx/Nx) animal model of PAH at each stage of worsening disease. Our hypothesis was that animals that were preselected as runners would have increased walk times and improved right ventricle/left ventricle plus septum (RV/LV+S) ratios, echocardiography, and histology compared with nonexercised Su/Hx/Nx animals. We examined four groups of rats: Su/Hx/Nx sedentary, Su/Hx/Nx exercised, control sedentary, and control exercised. Echocardiography was performed at 5, 8, and 13 weeks to assess right ventricular inner diameter in diastole and left ventricular eccentricity index. We found no difference between exercised and sedentary Su/Hx/Nx rats, and both were worsened compared with controls. Rats were euthanized at 13 weeks, and we found that neither RV/LV+S nor the occurrence of occlusive lesions were influenced by exercise. Most interesting, however, was that despite progressive PAH development, exercised Su/Hx/Nx rats showed no decrease in time or distance for treadmill exercise. In all, our data suggest that, despite severe PAH development, Su/Hx/Nx rats retain the same treadmill exercise capacity as control animals.

Entities:  

Keywords:  animal models; exercise; pulmonary hypertension

Year:  2015        PMID: 26064461      PMCID: PMC4449247          DOI: 10.1086/681267

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  15 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Effects of exercise training in patients with idiopathic pulmonary arterial hypertension.

Authors:  F S de Man; M L Handoko; H Groepenhoff; A J van 't Hul; J Abbink; R J H Koppers; H P Grotjohan; J W R Twisk; H-J Bogaard; A Boonstra; P E Postmus; N Westerhof; W J van der Laarse; A Vonk-Noordegraaf
Journal:  Eur Respir J       Date:  2009-09       Impact factor: 16.671

3.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Authors:  L Taraseviciene-Stewart; Y Kasahara; L Alger; P Hirth; G Mc Mahon ; J Waltenberger; N F Voelkel; R M Tuder
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

4.  An echocardiographic index for separation of right ventricular volume and pressure overload.

Authors:  T Ryan; O Petrovic; J C Dillon; H Feigenbaum; M J Conley; W F Armstrong
Journal:  J Am Coll Cardiol       Date:  1985-04       Impact factor: 24.094

5.  Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension.

Authors:  Benjamin D Fox; Michael Kassirer; Israela Weiss; Yael Raviv; Nir Peled; David Shitrit; Mordechai R Kramer
Journal:  J Card Fail       Date:  2010-12-03       Impact factor: 5.712

6.  Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.

Authors:  Dalia Urboniene; Idith Haber; Yong-Hu Fang; Thenappan Thenappan; Stephen L Archer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-25       Impact factor: 5.464

7.  Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.

Authors:  Derliz Mereles; Nicola Ehlken; Sandra Kreuscher; Stefanie Ghofrani; Marius M Hoeper; Michael Halank; F Joachim Meyer; Gabriele Karger; Jan Buss; Jana Juenger; Nicole Holzapfel; Christian Opitz; Jörg Winkler; Felix F J Herth; Heinrike Wilkens; Hugo A Katus; Horst Olschewski; Ekkehard Grünig
Journal:  Circulation       Date:  2006-09-18       Impact factor: 29.690

8.  Effects of exercise on monocrotaline-induced changes in right heart function and pulmonary artery remodeling in rats.

Authors:  Rafael Colombo; Rafaela Siqueira; Cristiano Urbano Becker; Tânia Gatelli Fernandes; Karla Maria Pires; Samuel Santos Valença; Maristela Padilha Souza-Rabbo; Alex Sander Araujo; Adriane Belló-Klein
Journal:  Can J Physiol Pharmacol       Date:  2013-01-01       Impact factor: 2.273

9.  Opposite effects of training in rats with stable and progressive pulmonary hypertension.

Authors:  M L Handoko; F S de Man; C M Happé; I Schalij; R J P Musters; N Westerhof; P E Postmus; W J Paulus; W J van der Laarse; A Vonk-Noordegraaf
Journal:  Circulation       Date:  2009-06-22       Impact factor: 29.690

10.  Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.

Authors:  Michie Toba; Abdallah Alzoubi; Kealan D O'Neill; Salina Gairhe; Yuri Matsumoto; Kaori Oshima; Kohtaro Abe; Masahiko Oka; Ivan F McMurtry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-15       Impact factor: 4.733

View more
  2 in total

1.  Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.

Authors:  Chun Zhou; Edward S Crockett; Lynn Batten; Ivan F McMurtry; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

Review 2.  Exercise for the heart: signaling pathways.

Authors:  Lichan Tao; Yihua Bei; Haifeng Zhang; Junjie Xiao; Xinli Li
Journal:  Oncotarget       Date:  2015-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.